Targeted genetic therapies for inherited disorders that affect both cardiac and skeletal muscle
Experimental Physiology · 2024-02 · 109 (2) · 175-189
DOI: 10.1113/ep090436 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Experimental Physiology, online erschienen am 14.12.2023. Verfasst von Yiangos Psaras und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Muscle, Skeletal, Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
Skeletal myopathies and ataxias with secondary cardiac involvement are complex, progressive and debilitating conditions. As life expectancy increases across these conditions, cardiac involvement often becomes more prominent. This highlights the need for targeted therapies that address these evolving cardiac pathologies. Musculopathies by and large lack cures that directly target the genetic basis of the diseases; however, as our understanding of the genetic causes of these conditions has evolved, it has become tractable to develop targeted therapies using biologics, to design precision approaches to target the primary genetic causes of these varied diseases. Using the examples of Duchenne muscular dystrophy, Friedreich ataxia and Pompe disease, we discuss how the genetic causes of such diseases derail diverse homeostatic, energetic and signalling pathways, which span multiple cellular systems in varied tissues across the body. We outline existing therapeutics and treatments in the context of emerging novel genetic approaches. We discuss the hurdles that the field must overcome to deliver targeted therapies across the many tissue types affected in primary myopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
ORCID-Profile: Christopher N Toepfer
Förderung
- Wellcome Trust
Zitieren
APA
Psaras, Y., & Toepfer, C. N. (2024). Targeted genetic therapies for inherited disorders that affect both cardiac and skeletal muscle. Experimental Physiology, 109(2), 175-189. https://doi.org/10.1113/ep090436
Vancouver
Psaras Y, Toepfer CN. Targeted genetic therapies for inherited disorders that affect both cardiac and skeletal muscle. Experimental Physiology. 2024;109(2):175-189. doi:10.1113/ep090436
BibTeX
@article{Psaras2024,
author = {Psaras, Yiangos and Toepfer, Christopher N},
title = {Targeted genetic therapies for inherited disorders that affect both cardiac and skeletal muscle},
journal = {Experimental Physiology},
year = {2024},
volume = {109},
number = {2},
pages = {175--189},
doi = {10.1113/ep090436}
}
EUVIMED